Human papillomavirus vaccine effectiveness and herd protection in young women

C Spinner, L Ding, DI Bernstein, DR Brown… - …, 2019 - publications.aap.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
被引用次数：96 相关文章

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women

C Spinner, L Ding, DI Bernstein, DR Brown… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Clinical trials of the 4-valent human papillomavirus (HPV) vaccine demonstrate
high efficacy, but surveillance studies are essential to examine the long-term impact of …

[引用][C] Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women

C Spinner, L Ding, DI Bernstein, DR Brown, EL Franco… - Pediatrics, 2019 - go.gale.com

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

C Spinner, L Ding, DI Bernstein, DR Brown, EL Franco… - Pediatrics, 2019 - europepmc.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …

Human papillomavirus vaccine effectiveness and herd protection in young women.

C Spinner, DLL Ding LiLi, DI Bernstein, DR Brown… - 2019 - cabidigitallibrary.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
[HTML] nih.gov

[HTML][HTML] Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women

C Spinner, L Ding, DI Bernstein, DR Brown, EL Franco… - Pediatrics, 2019 - ncbi.nlm.nih.gov
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

C Spinner, L Ding, DI Bernstein, DR Brown, EL Franco… - Pediatrics, 2019 - europepmc.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …